CDK2 knockdown enhances head and neck cancer cell radiosensitivity

References

• Agami R, Bernards R. 2000. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 102:55–66.
   PubMed Web of Science ®Google Scholar
• Aleem E, Kaldis P. 2006. Mouse models of cell cycle regulators: New paradigms. Results and Problems in Cell Differentiation 42:271–328.
   PubMedGoogle Scholar
• Aleem E, et al. 2004. Cdk2 as a master of S phase entry: Fact or fake? Cell Cycle 3:35–37.
   PubMed Web of Science ®Google Scholar
• Aleem E, et al. 2005. Cdc2-cyclin E complexes regulate the G1/S phase transition. Nature Cell Biology 7:831–836.
   PubMed Web of Science ®Google Scholar
• Berthet C, et al. 2003. Cdk2 knockout mice are viable. Current Biology 13:1775–1785.
   PubMed Web of Science ®Google Scholar
• Boyer MJ, Cheng T. 2008. The CDK inhibitors: Potential targets for therapeutic stem cell manipulations? Gene Therapy 15:117–125.
   PubMedGoogle Scholar
• Byrd JC, et al. 2007. Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia. Blood 109:399–404.
   PubMed Web of Science ®Google Scholar
• Chung JH, Bunz F. 2010. Cdk2 is required for p53-independent G2/M checkpoint control. PLoS Genetics 6:e1000863.
   PubMed Web of Science ®Google Scholar
• Cordes N, et al. 2007. Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1. Oncogene 26: 6851–6862.
   PubMed Web of Science ®Google Scholar
• Deans AJ, et al. 2006. Cyclin-dependent kinase 2 functions in normal DNA repair and is a therapeutic target in BRCA1-deficient cancers. Cancer Research 66:8219–8226.
   PubMed Web of Science ®Google Scholar
• Dikomey E, Brammer I. 2000. Relationship between cellular radiosensitivity and non-repaired double-strand breaks studied for different growth states, dose rates and plating conditions in a normal human fibroblast line. International Journal of Radiation Biology 76:773–781.
   PubMed Web of Science ®Google Scholar
• Diril MK, et al. 2012. Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration. Proceedings of the National Academy of Science of the USA 109:3826–3831.
   PubMed Web of Science ®Google Scholar
• Dyson N. 1998. The regulation of E2F by pRB-family proteins. Genes and Development 12:2245–2262.
   PubMed Web of Science ®Google Scholar
• Eke I, Cordes N. 2011. Radiobiology goes 3D: How ECM and cell morphology impact on cell survival after irradiation. Radiotherapy and Oncology 99:271–278.
   PubMed Web of Science ®Google Scholar
• Eke I, et al. 2007. Pharmacological inhibition of EGFR tyrosine kinase affects ILK-mediated cellular radiosensitization in vitro. International Journal of Radiation Biology 83:793–802.
   PubMed Web of Science ®Google Scholar
• Eke I, et al. 2012a. EGFR/JIP-4/JNK2 signaling attenuates cetuximab-mediated radiosensitization of squamous cell carcinoma cells. Cancer Research 73:297–306.
   PubMedGoogle Scholar
• Eke I, et al. 2012b. beta(1)Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy. Journal of Clinical Investigation 122:1529–1540.
   PubMed Web of Science ®Google Scholar
• Galons H, et al. 2010. Cyclin-dependent kinase inhibitors: A survey of recent patent literature. Expert Opinion on Therapeutic Patents 20:377–404.
   PubMed Web of Science ®Google Scholar
• Goga A, et al. 2007. Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC. Nature Medicine 13:820–827.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell 144:646–674.
   PubMed Web of Science ®Google Scholar
• Hehlgans S, et al. 2012. Targeting FAK radiosensitizes 3-dimensional grown human HNSCC cells through reduced Akt1 and MEK1/2 signaling. International Journal of Radiation Oncology Biology Physics 83:e669–76.
   Web of Science ®Google Scholar
• Jeggo P, Lobrich M. 2006. Radiation-induced DNA damage responses. Radiation Protection Dosimetry 122:124–127.
   PubMed Web of Science ®Google Scholar
• Kaldis P, Aleem E. 2005. Cell cycle sibling rivalry: Cdc2 vs. Cdk2. Cell Cycle 4:1491–1494.
   PubMed Web of Science ®Google Scholar
• Karnoub AE, Weinberg RA. 2008. Ras oncogenes: Split personalities. Nature Reviews Molecular Cell Biology 9:517–531.
   PubMed Web of Science ®Google Scholar
• Karunagaran D, et al. 2007. Cell growth regulation. Advances in Experimental Medicine and Biology 595:245–268.
   PubMedGoogle Scholar
• Kim SJ, et al. 2008. Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer. Annals of Oncology 19:68–72.
   PubMedGoogle Scholar
• Lu C, et al. 2012. Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans. PLoS One 7:e34833.
   PubMed Web of Science ®Google Scholar
• Malumbres M, et al. 2008. CDK inhibitors in cancer therapy: What is next? Trends in Pharmacological Sciences 29:16–21.
   PubMed Web of Science ®Google Scholar
• Morgan DO. 1997. Cyclin-dependent kinases: Engines, clocks, and microprocessors. Annual Reviews of Cell and Developmental Biology 13:261–291.
   PubMed Web of Science ®Google Scholar
• Müller-Tidow C, et al. 2004. The cyclin A1-CDK2 complex regulates DNA double-strand break repair. Molecular and Cellular Biology 24:8917–8928.
   PubMed Web of Science ®Google Scholar
• Neganova I, et al. 2011. An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells. Stem Cells 29:651–659.
   PubMed Web of Science ®Google Scholar
• Ohtsubo M, Roberts JM. 1993. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259:1908–1912.
   PubMed Web of Science ®Google Scholar
• Ortega S, et al. 2003. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nature Genetics 35:25–31.
   PubMed Web of Science ®Google Scholar
• Pagano M, et al. 1994. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes and Development 8:1627–1639.
   PubMed Web of Science ®Google Scholar
• Pampaloni F, et al. 2007. The third dimension bridges the gap between cell culture and live tissue. Nature Reviews Molecular Cell Biology 8:839–845.
   PubMed Web of Science ®Google Scholar
• Resnitzky D, et al. 1994. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Molecular and Cellular Biology 14:1669–1679.
   PubMed Web of Science ®Google Scholar
• Riabowol K, et al. 1989. The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells. Cell 57:393–401.
   PubMed Web of Science ®Google Scholar
• Sandfort V, et al. 2007. Cell adhesion-mediated radioresistance revisited. International Journal of Radiation Biology 83:727–732.
   PubMed Web of Science ®Google Scholar
• Satyanarayana A, Kaldis P. 2009. A dual role of Cdk2 in DNA damage response. Cell Division 4:9.
   PubMed Web of Science ®Google Scholar
• Satyanarayana A, et al. 2008. p21 inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint. Molecular Biology of the Cell 19:65–77.
   PubMed Web of Science ®Google Scholar
• Shapiro GI. 2006. Cyclin-dependent kinase pathways as targets for cancer treatment. Journal of Clinical Oncology 24:1770–1783.
   PubMed Web of Science ®Google Scholar
• Sherr CJ, Roberts JM. 1999. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes and Development 13:1501–1512.
   PubMed Web of Science ®Google Scholar
• Sherr CJ, Roberts JM. 2004. Living with or without cyclins and cyclin-dependent kinases. Genes and Development 18:2699–2711.
   PubMed Web of Science ®Google Scholar
• Siemeister G, et al. 2006. Molecular and pharmacodynamic characteristics of the novel multi-target tumor growth inhibitor ZK 304709. Biomedicine and Pharmacotherapy 60:269–272.
   PubMed Web of Science ®Google Scholar
• Sinclair WK, Morton RA. 1963. Variations in X-ray response during the division cycle of partially synchronized chinese hamster cells in culture. Nature 199:1158–1160.
   PubMed Web of Science ®Google Scholar
• Sinclair WK, Morton RA. 1966. X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. Radiation Research 29:450–474.
   PubMed Web of Science ®Google Scholar
• Singhal S, et al. 2003. Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling. Cancer Biology and Therapy 2:291–298.
   PubMed Web of Science ®Google Scholar
• Storch K, et al. 2010. Three-dimensional cell growth confers radioresistance by chromatin density modification. Cancer Research 70: 3925–3934.
   PubMed Web of Science ®Google Scholar
• Wei Y, et al. 2011. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nature Cell Biology 13:87–94.
   PubMed Web of Science ®Google Scholar
• Wohlbold L, et al. 2012. Chemical genetics reveals a specific requirement for cdk2 activity in the DNA damage response and identifies nbs1 as a cdk2 substrate in human cells. PLoS Genetics 8:e1002935.
   PubMedGoogle Scholar
• Xu R, et al. 2009. Tissue architecture and function: Dynamic reciprocity via extra- and intra-cellular matrices. Cancer and Metastasis Reviews 28:167–176.
   PubMed Web of Science ®Google Scholar
• Yu Q, Sicinski P. 2004. Mammalian cell cycles without cyclin E-CDK2. Cell Cycle 3:292–295.
   PubMedGoogle Scholar
• Zhang C, et al. 2011. Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance. PLoS One 6:e23849.
   PubMedGoogle Scholar
• Zschenker O, et al. 2012. Genome-wide gene expression analysis in cancer cells reveals 3D growth to affect ECM and processes associated with cell adhesion but not DNA repair. PLoS One 7:e34279.
   Google Scholar